oral glp-1 drugs in development Emerging Trends the of Receptor Agonists Emerging Weight Loss Drugs and
Description
Amphetamine craze: Desoxyn, Pondimin, and Redux showed promise but were pulled due to safety concerns
The Pharmaceutical Journal
Lewis, K
Patient characteristics affecting the tumor risk of GLP-1RAs Age and gender Meta-analyses have demonstrated that GLP-1RAs reduce the risk of prostate cancer, particularly in older male populations [115]
The data for Week 26 were then analyzed with an ANCOVA model containing treatment, sex, and age group as fixed effects and baseline value as covariate
